Jean Philippe Galanaud, Jean Pierre Laroch, and Marc Righini on Historical Treatments of DVT
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”The history and historical treatments of deep vein thrombosis: toward the era of new anticoagulants
By Jean Philippe Galanaud, Jean Pierre Laroch, and Marc Righini
• Context: Over centuries, the management of deep vein thrombosis (DVT) has evolved from empirical bloodletting to the precision of direct oral anticoagulants (DOACs).
• Overview: This historical review traces how DOACs revolutionized therapy—simplifying treatment, redefining duration and intensity, and reshaping clinical guidelines.
• Reflection: Despite progress, the “philosopher’s stone” of anticoagulation—perfect safety without loss of efficacy—remains elusive. Novel FXI/XIa inhibitors and AI-guided individualized therapy may herald the next transformation in DVT care.”
Read the full article in JTH.
Article: The history and historical treatments of deep vein thrombosis: toward the era of new anticoagulants
Authors: Jean Philippe Galanaud, Jean Pierre Laroch, Marc Righini
Stay updated on all scientific advances with Hemostasis Today.
-
Dec 19, 2025, 06:13Anna Aldehag Reflects on Her 12 Year Leadership in Sweden National Board of Health and Welfare
-
Dec 19, 2025, 05:54Abdul Mannan: APTT Mixing Studies Confuse a Lot of People
-
Dec 18, 2025, 23:14The “Normal” FVIII Level Trap in Females with Haemophilia
-
Dec 18, 2025, 23:11WFH Expands Multidisciplinary Bleeding Disorder Training in Vietnam
-
Dec 18, 2025, 17:13Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
-
Dec 18, 2025, 16:50Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
-
Dec 18, 2025, 16:26Yogesh Rathod on Hematological Issues and ICU
-
Dec 18, 2025, 16:09Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
-
Dec 18, 2025, 15:23Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals